Andrew Koven

This profile gathers the share dealings of Andrew Koven in Aralez Pharmaceuticals Inc. We count 16 filings; the first trade dates from 5 February 2016 and the latest from 14 May 2018.

Market trades split into 1 purchase (€171k) and 9 sales (€165k). Purchases outweigh sales by €6,022. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 5 option exercises. In 2018 alone, the filings show no purchases and 2 sales.

Most recently, on 16 May 2018, the filings show an option exercise worth €12k in Aralez Pharmaceuticals Inc. The clock since the last published purchase (17 May 2016) now reads 3,827 days. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.